1 Introduction Cancer remains a leading cause of morbidity and mortality worldwide, affecting millions of individuals each year (1)
This molecule is degraded by the body after a few minutes
The SHAPE study, analyzing real-world prescribing data, found: At 3 months: tirzepatide users lost 5.9% of body weight versus 3.6% for semaglutide At 6 months: 10.1% versus 5.8% At 12 months: 15.3% versus 8.3% These are averages from actual patients, not trial participants
Not Suitable For Breast-feeding women
These solutions help regulate your appetite, assist metabolism and release fat deposits
Zhang J, Ren X, Nie Z, You Y, Zhu Y, Chen H, et al